Hanne Opsand

Increased interleukin-6 and macrophage chemoattractant protein-1 are associated with respiratory failure in COVID-19

T. Ueland, P. Aukrust, S. Pischke, 2020, Scientific Reports.

Efficacy and safety of baricitinib in hospitalized adults with severe or critical COVID-19 (Bari-SolidAct): a randomised, double-blind, placebo-controlled phase 3 trial

Inge Christoffer Olsen, F. Lund-Johansen, Mariana H. S. Bernardo, 2023, Critical Care.